Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Kirklin Clinic
mi
from
Birmingham, AL
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
UAB Hospital Department of Pharmacy IDS
mi
from
Birmingham, AL
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
UAB Hospital Department of Pharmacy IDS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona - Mayo Clinic Speciality Building
mi
from
Phoenix, AZ
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona - Mayo Clinic Speciality Building
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona - Mayo Clinic Building
mi
from
Scottsdale, AZ
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona - Mayo Clinic Building
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
UCSD Clinical and Translational Research Institute, Investigational Drug Service
mi
from
La Jolla, CA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
UCSD Clinical and Translational Research Institute, Investigational Drug Service
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center, Investigational Drug Pharmacy Services
mi
from
Los Angeles, CA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center, Investigational Drug Pharmacy Services
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Care Foundation
mi
from
Los Angeles, CA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Care Foundation
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
University of Miami Hospital and Clinics
mi
from
Miami, FL
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
University of Miami Hospital and Clinics
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Northwestern Medical Group
mi
from
Chicago, IL
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Northwestern Medical Group
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Advocate Christ Medical Centre
mi
from
Oak Lawn, IL
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Advocate Christ Medical Centre
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital IDS Pharmacy
mi
from
Baltimore, MD
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital IDS Pharmacy
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Boston Medical Center - Cardiovascular Center, Outpatient Clinic
mi
from
Boston, MA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Boston Medical Center - Cardiovascular Center, Outpatient Clinic
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Boston Medical Center Investigational Pharmacy Services
mi
from
Boston, MA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Boston Medical Center Investigational Pharmacy Services
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center General Clinical Research Unit
mi
from
Boston, MA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center General Clinical Research Unit
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Pharmacy Research Supp
mi
from
Rochester, MN
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Pharmacy Research Supp
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Doctors Faculty Practice
mi
from
New York, NY
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Doctors Faculty Practice
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
The Mount Sinai Hospital Department of Pharmacy
mi
from
New York, NY
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
The Mount Sinai Hospital Department of Pharmacy
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center/Clinical Cardiovascular Research Laboratory for the Elderly
mi
from
New York, NY
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center/Clinical Cardiovascular Research Laboratory for the Elderly
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
OHSU Center for Health and Healing
mi
from
Portland, OR
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
OHSU Center for Health and Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
OHSU Research Pharmacy Services
mi
from
Portland, OR
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
OHSU Research Pharmacy Services
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated:  12/31/1969
VCU Medical Center - Ambulatory Care Clinic
mi
from
Richmond, VA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
A MULTICENTER, INTERNATIONAL, PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE (PF-06291826) 20 MG OR 80 MG IN COMPARISON TO PLACEBO IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY (TTR-CM)
Status: Enrolling
Updated: 12/31/1969
VCU Medical Center - Ambulatory Care Clinic
mi
from
Richmond, VA
Click here to add this to my saved trials
Right Ventricular Failure After Implantation of Left Ventricular Assist Devices
Right Ventricular Failure After Implantation of Left Ventricular Assist Devices
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Right Ventricular Failure After Implantation of Left Ventricular Assist Devices
Right Ventricular Failure After Implantation of Left Ventricular Assist Devices
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials
V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds
A Prospective, Open, Comparative, Randomized Single-center Study to Evaluate the Effect of V.A.C. VeraFlo™ Therapy With .125% Dakins vs V.A.C. Ulta™ Therapy on Biofilm Removal/Disruption/Elimination in Chronically Infected Wounds
Status: Enrolling
Updated:  12/31/1969
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds
A Prospective, Open, Comparative, Randomized Single-center Study to Evaluate the Effect of V.A.C. VeraFlo™ Therapy With .125% Dakins vs V.A.C. Ulta™ Therapy on Biofilm Removal/Disruption/Elimination in Chronically Infected Wounds
Status: Enrolling
Updated: 12/31/1969
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
Status: Enrolling
Updated:  12/31/1969
David Grant USAF Medical Center
mi
from
Travis Air Force Base, CA
Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
Assessment of Coronary Artery Calcium in Active Duty Enlisted Military Members With 10 or More Years of Service
Status: Enrolling
Updated: 12/31/1969
David Grant USAF Medical Center
mi
from
Travis Air Force Base, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Research
mi
from
Castro Valley, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Research
mi
from
Fair Oaks, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Research
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Limb Preservation Platform
mi
from
Fresno, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Limb Preservation Platform
mi
from
Fresno, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
VA Loma Linda Healthcare System
mi
from
Loma Linda, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
VA Loma Linda Healthcare System
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Atlanta Veteran's Administration
mi
from
Decatur, GA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Atlanta Veteran's Administration
mi
from
Decatur, GA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
VA Western New York Health Care System
mi
from
Buffalo, NY
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
VA Western New York Health Care System
mi
from
Buffalo, NY
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Research, Inc.
mi
from
Eugene, OR
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Research, Inc.
mi
from
Eugene, OR
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
Allegheny Singer Research Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
William Jennings Bryan Dorn Veterans Affairs Medical Center
mi
from
Columbia, SC
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
William Jennings Bryan Dorn Veterans Affairs Medical Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
ILD Research
mi
from
Carlsbad, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
ILD Research
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
SGM Physicians
mi
from
Haverford, PA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
SGM Physicians
mi
from
Haverford, PA
Click here to add this to my saved trials
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated:  12/31/1969
VA Northern California
mi
from
Mather, CA
Use of dHACM in the Treatment of Venous Leg Ulcers
A Randomized Controlled Clinical Trial Evaluating The Application Of Dehydrated Human Amnion/ Chorion Membrane (dHACM) Plus Standard Of Care Vs. Standard Of Care Alone In The Treatment Of Venous Leg Ulcers
Status: Enrolling
Updated: 12/31/1969
VA Northern California
mi
from
Mather, CA
Click here to add this to my saved trials
A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
A Phase IIB Pilot Study to Confirm the Feasibility and Tolerability of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
A Phase IIB Pilot Study to Confirm the Feasibility and Tolerability of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Evaluation of Predictors of Aortic Aneurysm Growth and Rupture
Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center, Division of Vascular Surgery
mi
from
Pittsburgh, PA
Evaluation of Predictors of Aortic Aneurysm Growth and Rupture
Aortic Wall Behavior as a Predictor of Aortic Aneurysm Growth and Rupture
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center, Division of Vascular Surgery
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
FREEZE Cohort Study
FREEZE Cohort Study
Status: Enrolling
Updated:  12/31/1969
Mission Hospital, Inc
mi
from
Asheville, NC
FREEZE Cohort Study
FREEZE Cohort Study
Status: Enrolling
Updated: 12/31/1969
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
FREEZE Cohort Study
FREEZE Cohort Study
Status: Enrolling
Updated:  12/31/1969
Allgemeines KH Linz
mi
from
Linz,
FREEZE Cohort Study
FREEZE Cohort Study
Status: Enrolling
Updated: 12/31/1969
Allgemeines KH Linz
mi
from
Linz,
Click here to add this to my saved trials
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Main
mi
from
Cleveland, OH
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Main
mi
from
Cleveland, OH
Click here to add this to my saved trials
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
Huntsville Hospital
mi
from
Huntsville, AL
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
Huntsville Hospital
mi
from
Huntsville, AL
Click here to add this to my saved trials
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
Mercy General Hospital
mi
from
Sacramento, CA
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
Mercy General Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
University of California San Diego Medical Center
mi
from
San Diego, CA
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
University of California San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials